P. Schmid

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Ludwig-Maximilians-Universität München(Current)

Kliniken Essen-Mitte

P. Schmid is an author at Ludwig-Maximilians-Universität München specializing in neoadjuvant therapy, neoadjuvant hormonal therapy, and breast cancer hormone therapy.

Publications per year

2024–2025

Publications

LBA4 Neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for high-risk early-stage TNBC: Overall survival results from the phase III KEYNOTE-522 study

P. Schmid, J. Cortés, R. Dent et al. · Annals of Oncology · 2024 · 14 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

189O Ribociclib + endocrine treatment vs SoC chemotherapy in intermediate risk HR+/HER2- early breast cancer: Results from the neoadjuvant cohort of the phase-III WSG ADAPTcycle – trial

N. Harbeck, Oleg Gluz, M Christgen et al. · ESMO Open · 2025 · 10 citations · Full text

Medicine, Endocrinology, Oncology +17

1–2 of 2